Published online Nov 16, 2021. doi: 10.12998/wjcc.v9.i32.9869
Peer-review started: June 22, 2021
First decision: July 5, 2021
Revised: July 16, 2021
Accepted: August 25, 2021
Article in press: August 25, 2021
Published online: November 16, 2021
The incidence of colorectal cancer is on the rise. The immune function of patients with colorectal cancer after adjuvant chemoradiotherapy affects their quality of life.
Traditional Chinese medicine (TCM) has demonstrated great potential in improving patients’ clinical symptoms, regulating the immune function, improving the life quality, and reducing the adverse effects (AEs) of chemotherapy.
This study aimed to observe the clinical efficacy of Yiqi Jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation.
The scores of TCM symptoms, Karnofsky performance scale (KPS) score, levels of T-cell subsets, and AEs after chemotherapy of the two groups were observed.
Compared with the control group, the experimental group improved significantly in scores of TCM symptoms, KPS score, levels of T-cell subsets, and AEs of chemo
Yiqi Jianpi anti-cancer prescription can effectively improve spleen deficiency, regulate the immune function, alleviate the AEs of chemotherapy, and improve the life quality of patients with good therapeutic effects and application prospect in clinical practice.
Yiqi Jianpi anti-cancer prescription can be further used in clinical practice. It can invigorate qi, promote the spleen, dissipate mass, and detoxify. It can also improve spleen deficiency and the life quality of patients.